Home > Balance Sheet > EMCURE PHARMACEUTICALS

EMCURE PHARMACEUTICALS
Total Non-Current Liabilities

    Back to Balance Sheet
EMCURE PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for EMCURE PHARMACEUTICALS
Please provide your vote to see the results

EMCURE PHARMACEUTICALS Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Total Non-Current Liabilities ₹1,377 Cr₹905 Cr₹868 Cr₹883 Cr₹899 Cr

What is the latest Total Non-Current Liabilities ratio of EMCURE PHARMACEUTICALS ?

The latest Total Non-Current Liabilities ratio of EMCURE PHARMACEUTICALS is ₹1,377 Cr based on Mar2024 Consolidated results.
Year Total Non-Current Liabilities
Mar2024₹1,377 Cr
Mar2023₹905 Cr
Mar2022₹868 Cr
Mar2021₹883 Cr
Mar2020₹899 Cr

How is Total Non-Current Liabilities of EMCURE PHARMACEUTICALS Trending?

Years Total Non-Current Liabilities % Change
Mar2024 ₹1,377 Cr
52.24
Mar2023 ₹905 Cr
4.16
Mar2022 ₹868 Cr
-1.64
Mar2021 ₹883 Cr
-1.80
Mar2020 ₹899 Cr -

Compare Total Non-Current Liabilities of peers of EMCURE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS ₹27,011.3 Cr 4.5% 6.2% 0.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹402,620.0 Cr -1.3% 1% 7.9% Stock Analytics
DIVIS LABORATORIES ₹175,509.0 Cr -3.2% -0.3% 48% Stock Analytics
TORRENT PHARMACEUTICALS ₹118,571.0 Cr 1.2% 10.7% 19.5% Stock Analytics
CIPLA ₹118,336.0 Cr -0.6% -2.2% -0.7% Stock Analytics
DR REDDYS LABORATORIES ₹103,522.0 Cr -1.5% -5.9% -5.1% Stock Analytics


EMCURE PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS

4.5%

6.2%

0.3%

SENSEX

-0.5%

-0.3%

1%


You may also like the below Video Courses